Search / 209 results found

from
to
  • Updated

SEATTLE, Dec. 15, 2020 /PRNewswire/ -- TwinStrand Biosciences, Inc., a next-generation DNA sequencing technology company, announced today the publication of a study validating a new application of its TwinStrand Duplex Sequencing(TM) Technology. Study findings demonstrated the ability of Duplex Sequencing to rapidly detect and characterize ultra-low frequency mutations and early cancer growth caused by chemical carcinogens in mouse models. The study, "Direct Quantification of in vivo Mutagenesis and Carcinogenesis Using Duplex Sequencing," was peer-reviewed and published in the Proceedings of the National Academy of Sciences (PNAS).

  • Updated

WASHINGTON, Dec. 15, 2020 /PRNewswire/ -- Over the last 30 years, significant progress has been made in the fight against cancer. Researchers have expanded their understanding of how cancer develops and how to target medicines for specific cancer types. Since peaking in 1991, the death rate associated with cancer declined by 29%, which translates to 2.9 million fewer cancer deaths. The most recent data shows that between 2016 and 2017 alone, cancer death rates declined by 2.2%, the largest single-year drop ever recorded. Despite the challenges imposed by the COVID-19 pandemic, this momentum continues with biopharmaceutical companies focusing on research and development of innovative cancer therapies.

  • Updated

RICHLAND, Wash., Dec. 7, 2020 /PRNewswire/ -- The costly treatment associated with childhood cancer can lead to long-term financial challenges, including questions of how to afford higher education. Northwestern Mutual is committed to helping children and families affected by this disease achieve their college dreams. As part of these efforts, Richland resident Sarah McKenna has been selected as a 2020 recipient through the company's Childhood Cancer Sibling Scholarship program.